RedHill Biopharma Ltd. announced the appointment of Mr. Ofer Tsimchi, an independent director of the Company, as the interim Chairman of the Board of Directors, effective May 5, 2023, until the next annual or extraordinary general meeting of shareholders of the Company. Mr. Ofer Tsimchi will replace Mr. Dror Ben-Asher, whose appointment as Chairman of the Board of Directors was approved by the Company's shareholders on May 4, 2020, for a period of three years. The Israeli Companies Law provides that the engagement of a Chief Executive Officer of an Israeli public company also as its Chairman of the Board of Directors requires shareholder approval, and such approval is effective for a period of up to three years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4581 USD | -0.04% | -1.02% | -68.62% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
1st Jan change | Capi. | |
---|---|---|
-68.62% | 1.46Cr | |
-2.29% | 8.99TCr | |
-3.95% | 3.76TCr | |
+63.05% | 2.65TCr | |
-22.14% | 1.43TCr | |
-7.96% | 1.3TCr | |
-9.33% | 1.19TCr | |
-46.33% | 1.08TCr | |
+5.77% | 911.12Cr | |
-17.66% | 732.39Cr |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Redhill Biopharma Ltd. Announces Board Changes